Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Steady-state pharmacokinetic interaction of modified-dose indinavir and rifabutin.

Steady-state pharmacokinetic interaction of modified-dose indinavir and rifabutin. Clin Pharmacol Ther. 2003 Mar; 73(3):159-69.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.